These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11317)

  • 1. A pharmacologic model of Huntington's chorea.
    Dill RE; Dorris RL; Phillips-Thonnard I
    J Pharm Pharmacol; 1976 Aug; 28(8):646-8. PubMed ID: 11317
    [No Abstract]   [Full Text] [Related]  

  • 2. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
    Groppetti A; Parenti M; Galli CL; Bugatti A; Cattabeni F; Di Giulio AM; Racagni G
    Life Sci; 1978 Oct; 23(17-18):1763-8. PubMed ID: 31531
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia.
    Ikeda H; Adachi K; Hasegawa M; Sato M; Hirose N; Koshikawa N; Cools AR
    J Neural Transm (Vienna); 1999; 106(11-12):1205-16. PubMed ID: 10651114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate neurotoxicity and Huntington's chorea.
    Olney JW; de Gubareff T
    Nature; 1978 Feb; 271(5645):557-9. PubMed ID: 146165
    [No Abstract]   [Full Text] [Related]  

  • 5. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
    Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
    Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
    Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
    Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Model of choreic movement in monkey--contribution for understanding the mechanism of chorea in Huntington's disease].
    Kanazawa I
    Jikken Dobutsu; 1990 Apr; 39(2):168-72. PubMed ID: 2141819
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.
    Friedhoff AJ; Bonnet K; Tosengarten H
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):411-23. PubMed ID: 847296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington's disease by day 18 fetal striatal implants.
    Deckel AW; Robinson RG; Coyle JT; Sanberg PR
    Eur J Pharmacol; 1983 Sep; 93(3-4):287-8. PubMed ID: 6227491
    [No Abstract]   [Full Text] [Related]  

  • 12. Impaired learning and memory after kainic acid lesions of the striatum: a behavioral model of Huntington's disease.
    Sanberg PR; Lehmann J; Fibiger HC
    Brain Res; 1978 Jun; 149(2):546-51. PubMed ID: 27285
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
    List SJ; Seeman P
    Life Sci; 1979 Apr; 24(16):1447-52. PubMed ID: 470544
    [No Abstract]   [Full Text] [Related]  

  • 14. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.
    Coyle JT; Schwarcz R
    Nature; 1976 Sep; 263(5574):244-6. PubMed ID: 8731
    [No Abstract]   [Full Text] [Related]  

  • 15. Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's chorea.
    Mason ST; Fibiger HC
    Brain Res; 1978 Oct; 155(2):313-29. PubMed ID: 28817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autoradiographic study on the pathogenesis of levodopa-induced dyskinesia: regulation of dopamine transporter by levodopa in a rat model of Parkinson's disease.
    Cai XY; Kong XM; Fang Q; Ning P; Xu YJ; Zhang B; Xue SR
    Neurodegener Dis; 2012; 9(1):11-7. PubMed ID: 21876323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
    Fenney A; Jog MS; Duval C
    Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration.
    Gao XM; Hashimoto T; Cooper TB; Tamminga CA
    J Neural Transm (Vienna); 1997; 104(1):97-104. PubMed ID: 9085197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the biochemical pharmacology of extrapyramidal movement disorders.
    Klawans HL; Goetz C; Nausieda PA; Weiner WJ
    Adv Exp Med Biol; 1977; 90():21-47. PubMed ID: 145167
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats.
    See RE; Chapman MA
    Eur J Pharmacol; 1994 Oct; 263(3):269-76. PubMed ID: 7843264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.